table 1.Selected Risk Fac<strong>to</strong>rs for and Recommendations <strong>to</strong> <strong>Prevent</strong> <strong>Surgical</strong> <strong>Site</strong> <strong>Infections</strong> (SSIs)Risk fac<strong>to</strong>r Recommendation Grade aIntr<strong>in</strong>sic, patient related (preoperative)UnmodifiableAgeModifiableGlucose control, diabetesObesitySmok<strong>in</strong>g cessationImmunosuppressive medicationsExtr<strong>in</strong>sic, procedure related (perioperative)Preparation of patientHair removalabPreoperative <strong>in</strong>fectionsOperative characteristics<strong>Surgical</strong> scrub (surgical team members’hands and forearms)Sk<strong>in</strong> preparationNo formal recommendation: relationship <strong>to</strong> <strong>in</strong>creased riskof SSI may be secondary <strong>to</strong> comorbidities or immunesenescence [28-30]Control serum blood glucose levels [5]; reduce glycosylatedhemoglob<strong>in</strong> A1c levels <strong>to</strong> !7% before surgery, ifpossible [31]Increase dos<strong>in</strong>g of prophylactic antimicrobial agent formorbidly obese patients [32]Encourage smok<strong>in</strong>g cessation with<strong>in</strong> 30 days beforeprocedure [5]No formal recommendation; <strong>in</strong> general, avoid immunosuppressivemedications <strong>in</strong> perioperative period, ifpossibleDo not remove unless hair will <strong>in</strong>terfere with the operation[5]; if hair removal is necessary, remove by clipp<strong>in</strong>gand do not use razorsIdentify and treat <strong>in</strong>fections (eg, ur<strong>in</strong>ary tract <strong>in</strong>fection)remote <strong>to</strong> the surgical site before elective surgery [5]Use appropriate antiseptic agent <strong>to</strong> perform 2-5–m<strong>in</strong>utepreoperative surgical scrub [5] or use an alcohol-basedsurgical hand antisepsis productWash and clean sk<strong>in</strong> around <strong>in</strong>cision site; use an appropriateantiseptic agent [5]Antimicrobial prophylaxis Adm<strong>in</strong>ister only when <strong>in</strong>dicated [5] A-ITim<strong>in</strong>gAdm<strong>in</strong>ister with<strong>in</strong> 1 hour before <strong>in</strong>cision <strong>to</strong> maximize A-Itissue concentration b [5, 33]ChoiceSelect appropriate agents on the basis of surgical procedure,most common pathogens caus<strong>in</strong>g SSI for aspecific procedure, and published recommendations [5,33]A-IDuration of therapyS<strong>to</strong>p prophylaxis with<strong>in</strong> 24 hours after the procedure forall procedures except cardiac surgery; for cardiacsurgery, antimicrobial prophylaxis should be s<strong>to</strong>ppedwith<strong>in</strong> 48 hours [5, 33]Surgeon skill/technique Handle tissue carefully and eradicate dead space [5] A-IIIAsepsisAdhere <strong>to</strong> standard pr<strong>in</strong>ciples of operat<strong>in</strong>g room asepsis A-III[5]Operative timeNo formal recommendation <strong>in</strong> most recent guidel<strong>in</strong>es;m<strong>in</strong>imize as much as possible [34]A-IIIOperat<strong>in</strong>g room characteristicsVentilationFollow American Institute of Architects’ recommendationsC-I[5]Traffic M<strong>in</strong>imize operat<strong>in</strong>g room traffic [5] B-IIEnvironmental surfacesUse a US Environmental Protection Agency–approvedhospital dis<strong>in</strong>fectant <strong>to</strong> clean surfaces and equipment[5]B-IIISterilization of surgical equipmentSee Table 2 for def<strong>in</strong>itions.Vancomyc<strong>in</strong> and fluoroqu<strong>in</strong>olones can be given 2 hours before <strong>in</strong>cision.Sterilize all surgical equipment accord<strong>in</strong>g <strong>to</strong> publishedguidel<strong>in</strong>es; m<strong>in</strong>imize the use of flash sterilization [5]…A-IIA-IIA-IIC-IIA-IA-IIA-IIA-IIA-IB-I
strategies for prevention of ssiS55b<strong>in</strong>ed <strong>in</strong><strong>to</strong> concise, efficient, and effective recommendationsthat are easily unders<strong>to</strong>od and remembered. 39ii. Provide education regard<strong>in</strong>g the outcomes associatedwith SSI, risks for SSI, and methods <strong>to</strong> reducerisk <strong>to</strong> all patients, patients’ families, surgeons, and perioperativepersonnel.iii. Education for patients and patients’ families is aneffective method <strong>to</strong> reduce risk associated with <strong>in</strong>tr<strong>in</strong>sicpatient-related SSI risk fac<strong>to</strong>rs. 40,41c. Computer-assisted decision support and au<strong>to</strong>matedrem<strong>in</strong>dersi. Several <strong>in</strong>stitutions have successfully employedcomputer-assisted decision-support methodology <strong>to</strong> improvethe rate of appropriate adm<strong>in</strong>istration of antimicrobialprophylaxis (<strong>in</strong>clud<strong>in</strong>g redos<strong>in</strong>g dur<strong>in</strong>g prolongedcases). 42-44ii. Computer-assisted decision support, however, ispotentially expensive, can be time consum<strong>in</strong>g <strong>to</strong> implement,and, <strong>in</strong> a s<strong>in</strong>gle study, was reported <strong>to</strong> <strong>in</strong>itially<strong>in</strong>crease the rate of adverse drug reactions. 45iii. Institutions must appropriately validate computer-assisteddecision-support systems after implementation.d. Utilization of au<strong>to</strong>mated datai. Install <strong>in</strong>formation technology <strong>in</strong>frastructure <strong>to</strong> facilitatedata transfer, receipt, and organization <strong>to</strong> aid withthe track<strong>in</strong>g of process and outcome measures.section 4: recommendations forimplement<strong>in</strong>g prevention andmoni<strong>to</strong>r<strong>in</strong>g strategiesRecommendations for prevent<strong>in</strong>g and moni<strong>to</strong>r<strong>in</strong>g SSIs aresummarized <strong>in</strong> the follow<strong>in</strong>g section. They are designed <strong>to</strong>assist acute care hospitals <strong>in</strong> prioritiz<strong>in</strong>g and implement<strong>in</strong>gtheir SSI prevention efforts. Criteria for grad<strong>in</strong>g of thestrength of recommendation and quality of evidence are described<strong>in</strong> Table 2.I. Basic practices for prevention and moni<strong>to</strong>r<strong>in</strong>g of SSI:recommended for all acute care hospitalsA. Surveillance of SSI1. Perform surveillance for SSI (A-II).a. Identify high-risk, high-volume operative procedures<strong>to</strong> be targeted for SSI surveillance on the basis of a riskassessment of patient populations, operative proceduresperformed, and available SSI surveillance data.b. Identify, collect, s<strong>to</strong>re, and analyze data needed forthe surveillance program. 5i. Implement a system for collect<strong>in</strong>g data needed <strong>to</strong>identify SSIs.ii. Develop a database for s<strong>to</strong>r<strong>in</strong>g, manag<strong>in</strong>g, and access<strong>in</strong>gcollected data on SSIs.iii. Prepare periodic SSI reports (the time frame willdepend on hospital needs and volume of targetedprocedures).iv. Collect denom<strong>in</strong>a<strong>to</strong>r data on all patients undergo<strong>in</strong>gtargeted procedures, <strong>to</strong> calculate SSI rates for eachtype of procedure. 39v. Identify trends (eg, <strong>in</strong> rates of SSI and pathogenscaus<strong>in</strong>g SSIs).c. Use Centers for Disease Control and <strong>Prevent</strong>ion NationalHealthcare Safety Network def<strong>in</strong>itions of SSI. 14d. Perform <strong>in</strong>direct surveillance for targeted procedures.19,20,47,48e. Perform pos<strong>to</strong>perative surveillance for 30 days; extendthe pos<strong>to</strong>perative surveillance period <strong>to</strong> 12 months ifprosthetic material is implanted dur<strong>in</strong>g surgery. 14f. Surveillance should be performed for patients readmitted<strong>to</strong> the hospital.i. If an SSI is diagnosed at your <strong>in</strong>stitution but thesurgical procedure was performed elsewhere, notify thehospital where the orig<strong>in</strong>al procedure was performed.g. Develop a system for rout<strong>in</strong>e review and <strong>in</strong>terpretationof SSI rates <strong>to</strong> detect significant <strong>in</strong>creases or outbreaksand <strong>to</strong> identify areas where additional resourcesmight be needed <strong>to</strong> improve SSI rates. 472. Provide ongo<strong>in</strong>g feedback on SSI surveillance and processmeasures <strong>to</strong> surgical and perioperative personnel andleadership (A-II).a. Rout<strong>in</strong>ely provide feedback on SSI rates and processmeasures <strong>to</strong> <strong>in</strong>dividual surgeons and hospital leadership. 5i. For each type of procedure performed, provide riskadjustedrates of SSI.ii. Anonymously benchmark procedure-specific riskadjustedrates of SSI among peer surgeons. 5b. Confidentially provide data <strong>to</strong> <strong>in</strong>dividual surgeons,the surgical division, and/or department chiefs.3. Increase the efficiency of surveillance through the useof au<strong>to</strong>mated data (A-II).a. Implement a method <strong>to</strong> electronically transfer operativedata, <strong>in</strong>clud<strong>in</strong>g process measures when available, <strong>to</strong><strong>in</strong>fection prevention and control personnel <strong>to</strong> facilitate acquisitionof denom<strong>in</strong>a<strong>to</strong>r data and calculation of SSI ratesfor various procedures.b. If <strong>in</strong>formation technology and <strong>in</strong>frastructure resourcesare available, develop au<strong>to</strong>mated methods for detectionof SSI by use of au<strong>to</strong>mated data on readmissions,microbiological test results, and antimicrobial dispens<strong>in</strong>g. 23i. Implementation of au<strong>to</strong>mated surveillance may improvethe sensitivity of surveillance.B. Practice1. Adm<strong>in</strong>ister antimicrobial prophylaxis <strong>in</strong> accordancewith evidence-based standards and guidel<strong>in</strong>es (A-I). 5,49,50